Why Moderna Stock Was Sluggish on Friday
A frequent riser because of its status as a top coronavirus stock, Moderna (NASDAQ: MRNA) was falling at roughly a 1% clip in late-afternoon trading Friday. As the company's mRNA-1273 is its only commercialized product so far, sentiment on the company was affected by some potentially bad news in Washington, D.C.
On Friday during a special argument session with lawyers, the Supreme Court's Chief Justice John Roberts cast doubt on the Biden administration's coronavirus vaccine mandate for employees at businesses that employ 100 or more workers.
Image source: Getty Images.
Source Fool.com